This validation data shows that the new SPP1 TAM signature is at least as sensitive and specific to SPP1 TAM cells as previous versions; however, it is more suitable for use with bulk sequencing samples that contain tumor and stromal cells since it does not pick up signal from those other cell types. The gene discussed is SPP1; the disease is neoplasm.